cilostazol has been researched along with Coronary Stenosis in 11 studies
Coronary Stenosis: Narrowing or constriction of a coronary artery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previously, in the ESCAPE study, a randomized controlled trial, we found that 12 months of cilostazol administration significantly decreased coronary artery stenosis and the noncalcified plaque component compared with aspirin." | 5.51 | Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long-term follow-up of the ESCAPE study. ( Chun, EJ; Lim, S; Sohn, M, 2022) |
| "Cilostazol was associated with a significant reduction in late loss in BMS (mean difference 0." | 3.84 | Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. ( Chen, KY; Chetcuti, S; Grossman, MP; Gurm, H; Meier, P; Rha, SW; Tamhane, U, 2009) |
| " Meta-analyses evaluated effectiveness and adverse side effects for one-month administrations of aspirin plus cilostazol or aspirin plus ticlopidine therapy after coronary stenting." | 3.81 | Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting. ( Hashiguchi, M; Kishino, S; Mochizuki, M; Nakazawa, R; Ohno, K; Shiga, T, 2004) |
| "Treatment with cilostazol is likely a cost-saving or dominant strategy in patients with successful coronary bare metal stent implantation." | 2.72 | Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial. ( Anderson, GT; Douglas, JS; Foster, JK; Jurkovitz, CT; Kolm, P; Murrah, NV; Parker, KM; Weintraub, WS; Zhang, Z, 2006) |
| "6 months, major adverse cardiac and cerebrovascular events (MACCE) occurred in 43 patients (17." | 1.39 | Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease. ( Choi, RK; Hwang, HK; Lee, HJ; Li, H; Park, JS; Ro, YM; Yu, CW, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Sohn, M | 1 |
| Chun, EJ | 1 |
| Lim, S | 1 |
| Lee, HJ | 1 |
| Yu, CW | 1 |
| Hwang, HK | 1 |
| Choi, RK | 1 |
| Park, JS | 1 |
| Li, H | 1 |
| Ro, YM | 1 |
| Jang, SW | 1 |
| Kim, DB | 1 |
| Kwon, BJ | 1 |
| Shin, D | 1 |
| Her, SH | 1 |
| Park, CS | 1 |
| Park, HJ | 2 |
| Park, MW | 1 |
| Cho, EJ | 1 |
| Rho, TH | 1 |
| Kim, JH | 1 |
| Tamhane, U | 1 |
| Meier, P | 1 |
| Chetcuti, S | 1 |
| Chen, KY | 1 |
| Rha, SW | 1 |
| Grossman, MP | 1 |
| Gurm, H | 1 |
| Lee, CW | 3 |
| Park, DW | 2 |
| Seung, KB | 1 |
| Kim, PJ | 1 |
| Kim, WJ | 1 |
| Lee, JY | 1 |
| Kang, SJ | 1 |
| Lee, SH | 1 |
| Kim, YH | 3 |
| Park, SW | 3 |
| Park, SJ | 3 |
| Hong, MK | 2 |
| Mintz, GS | 1 |
| Lee, SW | 3 |
| Song, JM | 1 |
| Han, KH | 1 |
| Kang, DH | 1 |
| Song, JK | 1 |
| Kim, JJ | 2 |
| Sekiguchi, M | 1 |
| Hoshizaki, H | 1 |
| Adachi, H | 1 |
| Ohshima, S | 1 |
| Taniguchi, K | 1 |
| Kurabayashi, M | 1 |
| Hashiguchi, M | 1 |
| Ohno, K | 1 |
| Nakazawa, R | 1 |
| Kishino, S | 1 |
| Mochizuki, M | 1 |
| Shiga, T | 1 |
| Han, Y | 1 |
| Wang, S | 1 |
| Li, Y | 1 |
| Jing, Q | 1 |
| Ma, Y | 1 |
| Deng, J | 1 |
| Yang, G | 1 |
| Yu, H | 1 |
| Ge, J | 1 |
| Zhang, Z | 1 |
| Foster, JK | 1 |
| Kolm, P | 1 |
| Jurkovitz, CT | 1 |
| Parker, KM | 1 |
| Murrah, NV | 1 |
| Anderson, GT | 1 |
| Douglas, JS | 1 |
| Weintraub, WS | 1 |
| Lee, BK | 1 |
| Jang, S | 1 |
| Chi, HS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Revascularization With Paclitaxel-coated Balloon Angioplasty Versus Drug-eluting Stenting in Acute Myocardial Infarction - a Randomized Controlled Trial.[NCT02219802] | 120 participants (Anticipated) | Interventional | 2014-08-31 | Not yet recruiting | |||
| Comparison of Platelet Inhibitory Effect With Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction Patients According to CYP2C19 Polymorphism[NCT00915733] | Phase 4 | 80 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cilostazol and Coronary Stenosis
| Article | Year |
|---|---|
Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Angiography; Coronary Restenosis | 2009 |
Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting.
Topics: Administration, Oral; Aspirin; Cilostazol; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; | 2004 |
8 trials available for cilostazol and Coronary Stenosis
| Article | Year |
|---|---|
Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long-term follow-up of the ESCAPE study.
Topics: Aspirin; Cilostazol; Coronary Artery Disease; Coronary Stenosis; Diabetes Mellitus, Type 2; Drug The | 2022 |
Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Angiography; Coronary Restenosis | 2009 |
Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cilostazol; Coronary | 2011 |
Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol.
Topics: Aged; Cilostazol; Coronary Restenosis; Coronary Stenosis; Equipment Design; Female; Follow-Up Studie | 2004 |
Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting.
Topics: Administration, Oral; Aspirin; Cilostazol; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; | 2004 |
Cilostazol improves long-term outcomes after coronary stent implantation.
Topics: Cilostazol; Coronary Restenosis; Coronary Stenosis; Humans; Platelet Aggregation Inhibitors; Prospec | 2005 |
Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial.
Topics: Adult; Cilostazol; Coronary Restenosis; Coronary Stenosis; Cost-Benefit Analysis; Double-Blind Metho | 2006 |
Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
Topics: Aspirin; Biomarkers; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Coronary Resteno | 2007 |
3 other studies available for cilostazol and Coronary Stenosis
| Article | Year |
|---|---|
Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease.
Topics: Aged; Cerebrovascular Disorders; Cilostazol; Coronary Restenosis; Coronary Stenosis; Coronary Thromb | 2013 |
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occ | 2010 |
Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
Topics: Aged; Aspirin; Atherectomy, Coronary; Catheterization; Cilostazol; Combined Modality Therapy; Corona | 2004 |